Trials / Recruiting
RecruitingNCT06504225
EVEROLD LONG TERM FOLLOW-UP
Long-term Evaluation of the Value of Using an MTor Inhibitor (everolimus) for the Minimisation of Anticalceurins in Old-for-old Kidney Transplantation
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 260 (estimated)
- Sponsor
- University Hospital, Brest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Long Term Follow up of EVEROLD study
Conditions
Timeline
- Start date
- 2024-08-23
- Primary completion
- 2025-08-01
- Completion
- 2025-08-01
- First posted
- 2024-07-16
- Last updated
- 2025-02-06
Locations
14 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06504225. Inclusion in this directory is not an endorsement.